Science-led regulatory strategies in nonclinical development of new medicines

被引:1
|
作者
Roberts, Ruth [1 ]
Jones, David [1 ]
机构
[1] ApconiX, Alderley Pk, Macclesfield SK10 4TG, England
关键词
Drug Discovery; Drug Development; Regulatory Guidelines; Decision making;
D O I
10.1093/toxres/tfad017
中图分类号
R99 [毒物学(毒理学)];
学科分类号
100405 ;
摘要
The development of a pharmaceutical is a stepwise process involving an evaluation of both animal and human efficacy and safety information. Regulations around drug development exist to protect people and the environment from harm and should create a level playing field for business, allowing well-run companies to thrive. However, adherence to good science should guide decisions rather than rigorously following guidelines, and there is almost always more than one way to get to the ultimate goal.
引用
收藏
页码:145 / 149
页数:5
相关论文
共 50 条
  • [21] Engineering science-led computer-aided design. A project-based approach
    Dunne, F.P.E.
    Taylor, D.A.W.
    International Journal of Mechanical Engineering Education, 1995, 23 (03)
  • [22] The Innovative Medicines Initiative: an engine for regulatory science
    Michel Goldman
    Nathalie Seigneuret
    Hans-Georg Eichler
    Nature Reviews Drug Discovery, 2015, 14 : 1 - 2
  • [23] The Innovative Medicines Initiative: an engine for regulatory science
    Goldman, Michel
    Seigneuret, Nathalie
    Eichler, Hans-Georg
    NATURE REVIEWS DRUG DISCOVERY, 2015, 14 (01) : 1 - 2
  • [24] Emerging Applications and Regulatory Strategies for Advanced Medicines Manufacturing - Towards the Development of a Platform Approach
    Srai, Jagjit Singh
    Bauer, Paul
    Badman, Clive
    Bresciani, Massimo
    Cooney, Charles L.
    Florence, Alastair
    Hausner, Doug
    Konstantinov, Konstantin
    Lee, Sau L.
    Mascia, Salvatore
    Nasr, Moheb
    Trout, Bernhardt L.
    JOURNAL OF PHARMACEUTICAL SCIENCES, 2024, 113 (07) : 1701 - 1710
  • [25] Explaining science-led policy-making: pandemic deaths, epistemic deliberation and ideational trajectories
    Erik Baekkeskov
    Policy Sciences, 2016, 49 : 395 - 419
  • [26] Medicines Regulatory Science Expertise in Africa: Workforce Capacity Development and Harmonisation Activities Towards the Establishment of the African Medicines Agency
    Bakani Mark Ncube
    Admire Dube
    Kim Ward
    Pharmaceutical Medicine, 2022, 36 : 83 - 97
  • [27] Medicines regulatory science expertise in Africa: Workforce capacity development and harmonisation activities towards the establishment of the African Medicines Agency
    Ncube, Bakani Mark
    Dube, Admire
    Ward, Kim
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2022, 31 : 660 - 660
  • [28] Medicines Regulatory Science Expertise in Africa: Workforce Capacity Development and Harmonisation Activities Towards the Establishment of the African Medicines Agency
    Ncube, Bakani Mark
    Dube, Admire
    Ward, Kim
    PHARMACEUTICAL MEDICINE, 2022, 36 (02) : 83 - 97
  • [29] The Evolution of Nonclinical Regulatory Science: Advanced Therapy Medicinal Products as a Paradigm
    Vestergaard, Henrik Tang
    D'Apote, Lucia
    Schneider, Christian K.
    Herberts, Carla
    MOLECULAR THERAPY, 2013, 21 (09) : 1644 - 1648
  • [30] A Paradigm Shift Towards Patient Involvement in Medicines Development and Regulatory Science: Workshop Proceedings and Commentary
    Gitte Borup
    Karin Friis Bach
    Merete Schmiegelow
    Helle Wallach-Kildemoes
    Ole Jannik Bjerrum
    Niels Westergaard
    Therapeutic Innovation & Regulatory Science, 2016, 50 : 304 - 311